1.Gallbladder carcinoma: CT staging and operation resectability
Xingyuan JIAO ; Mingji HE ; Yize HU
International Journal of Surgery 2008;35(4):245-247
Objective To analyze the CT staging and evaluate its role in assessing the resectability of the gallbladder carcinoma.Methods The CT scans of 47 patients who had pathologically confirmed gallbladder carcinoma were retrospectively reviewed and the CT stages of gallbladder carcinoma were used to evaluate the resectability.Results Before operation,three patients were in stage Ⅰ(6.4%,3/47),14stageⅡ(29.8%,14/47),10 stageⅢ(21.7%,3/47),20 stage Ⅳ(42.6%,20/47),however,after operation,three patients were in stage Ⅰ(6.4%,3/47),14 stageⅡ(29.8%,14/47),8 stage Ⅲ(17.0%%,8/47),22 stage Ⅳ(42.6%,20/47).The accurate rate of CT staging confirmed by operation was 91.5%(43/47).The treatment procedures of gallbladder carcinomas included radical operation,palliative excision and exploratory laparotomy.For 47 patients with gallbladder carcinomas,radical operation was performed in 30 cases(3 stage Ⅰ,14 stageⅡ,7 stage Ⅲ,6 stage Ⅳ),palliative excision 15 cases(1 stage Ⅲ,14 stage Ⅳ),exploratory laporatory 2 eases(2 stage Ⅳ).Conclusion The staging of gallbladder carcinoma with CT may provide definite value in evaluating respectability of gallbladder carcinoma.
2.Radioactive I-125 seed implantation in treatment of TACE-refractory hepatocellular carcinoma
Jingqiang WU ; Wensou HUANG ; Yongjian GUO ; Jingwen ZHOU ; Mingyue CAI ; Licong LIANG ; Jingjun HUANG ; Hui LIAN ; Mingji HE ; Kangshun ZHU
Chinese Journal of Hepatobiliary Surgery 2021;27(8):570-574
Objective:To study the use of radioactive I-125 seed implantation in the treatment of transarterial chemoembolization (TACE)-refractory hepatocellular carcinoma (HCC).Methods:A retrospective study was conducted on 70 patients with HCC who were initially treated with TACE between July 1, 2016 and August 31, 2019 at the Second Affiliated Hospital of Guangzhou Medical University. After these patients were found to be refractory to TACE, 29 patients were converted to radioactive I-125 seed implantation (the 125I seed group), and 41 patients were continued with TACE (the TACE group). The objective response rate, progression-free survival (PFS), overall survival (OS), total overall survival (TOS) of the two groups were compared. Results:There were 59 males and 11 females, aged (60.5±11.9 ) years in this study. At 1, 3, 6 months after treatment, the objective response rates of the 125I seed group were 20.7%, 40.7%, 34.6%, respectively, which were significantly higher than that of the TACE group of 2.6%, 3.3%, 5.0%, respectively. The PFS, OS, TOS in the 125I seed group were 7.6, 21.1, 32.1 months, respectively, which were significantly better when compared with the TACE group (3.5, 8.5, 14.8 months, respectively, all P<0.05). There was no significant difference in the embolization syndrome between the two groups [93.1%(27/29) vs 100.0%(41/41), P>0.05]. Child-Pugh B grading ( HR=0.311, 95% CI: 0.160-0.603, P=0.005) and TACE ( HR=0.308, 95% CI: 0.159-0.597, P=0.002) were independent risk prognostic factors for survival. Conclusion:This study showed better treatment efficacy and safety using radioactive I-125 seed implantation in TACE-refractory HCC and this treatment significantly improved survival of patients when compared with TACE alone.
3.Influence of hydrosalpinx on endometrial receptivity evaluated by transvaginal color doppler sonography
Mingji CAI ; Zhaoxia HE ; Linlin XIE ; Jianrong WANG ; Yanhong HU
Journal of Clinical Medicine in Practice 2014;(13):154-156
Objective To evaluate the influence of hydrosalpinx on endometrial receptivity by transvaginal color doppler sonography.Methods A total of 70 patients with hydrosalpinx were randomly divided into unilateral hydrosalpinx group (observation group A)and bilateral hydros-alpinx group (observation group B),35 cases for each.Another 35 diagnosed healthy parous women served as control group.Resistance indexes (RI)of uterine artery and blood distribution types in and under endometrium among 3 groups were compared.Results Observation groups A and B were obviously higher than control group in RI on hydrosalpinx side (P <0.01),whereas observation group A was evidently higher in types A and C blood distribution and observation group B in type A blood distribution than control group (P <0.05 or P <0.01).Conclusion Hydrosalpinx may has certain impact on hemodynamics of uterine artery and increase RI,leading to decreased blood distri-bution in and under endometrium and endometrial receptivity,which can affect pregnant rate subse-quently.
4.Influence of hydrosalpinx on endometrial receptivity evaluated by transvaginal color doppler sonography
Mingji CAI ; Zhaoxia HE ; Linlin XIE ; Jianrong WANG ; Yanhong HU
Journal of Clinical Medicine in Practice 2014;(13):154-156
Objective To evaluate the influence of hydrosalpinx on endometrial receptivity by transvaginal color doppler sonography.Methods A total of 70 patients with hydrosalpinx were randomly divided into unilateral hydrosalpinx group (observation group A)and bilateral hydros-alpinx group (observation group B),35 cases for each.Another 35 diagnosed healthy parous women served as control group.Resistance indexes (RI)of uterine artery and blood distribution types in and under endometrium among 3 groups were compared.Results Observation groups A and B were obviously higher than control group in RI on hydrosalpinx side (P <0.01),whereas observation group A was evidently higher in types A and C blood distribution and observation group B in type A blood distribution than control group (P <0.05 or P <0.01).Conclusion Hydrosalpinx may has certain impact on hemodynamics of uterine artery and increase RI,leading to decreased blood distri-bution in and under endometrium and endometrial receptivity,which can affect pregnant rate subse-quently.
5.Awareness Investigation and Strategy Analysis on Pharmaceutical Services and Fees in Hospitals in Guizhou Province
Dongmei LI ; Qian YANG ; Shuimei SUN ; Ling HE ; Dirong WU ; Mingji LIU ; Pingping CHEN ; Libin WANG ; Zhongyuan WANG ; Hong ZHANG ; Zhu ZHU ; Xue BAI ; Changcheng SHENG ; Jiaxing ZHANG ; Lei LU ; Xue WANG ; Qi CHEN
Herald of Medicine 2024;43(9):1410-1415
Objective To investigate the current status and awareness of pharmaceutical services in hospitals in Guizhou province and to provide a reference for exploring and carrying out pharmaceutical service fees.Methods The questionnaire was designed by the"wjx.cn"website.Three kinds of questionnaires were designed for pharmacists,doctors,nurses,and patients as the research objects,with corresponding differences in some questions,and promoted on WeChat,Dingxiangyuan,and other network platforms.Results A total of 655 questionnaires were collected,and 639 valid questionnaires were recovered,with an effective recovery rate of 97.56%.324 pharmacists(50.70%),82 doctors and nurses(12.83%),233 patients(36.46%)were surveyed.The average approval score of these three groups of respondents on pharmaceutical service fees was 4.67,4.23,and 4.22,respectively(full score:5).Conclusions Overall,pharmacists'professional services have received support from medical staff and patients.However,patients'pharmaceutical service projects currently focus on dispensing services.The recognition of pharmacists'work and the public's awareness of pharmaceutical services can be improved by enhancing the professional ability of pharmacists,strengthening publicity and guidance,and exploring"Internet+pharmaceutical services",etc.,to promote the sustainable development of pharmaceutical services.
6. MRI-visible and pH-sensitive nanomicelles for targeting delivery of sorafenib to hepatocellular carcinoma
Mingyue CAI ; Ge LYV ; Qin YANG ; Liteng LIN ; Jingjun HUANG ; Zhimei ZHOU ; Yong HUANG ; Hui LIAN ; Mingji HE ; Kangshun ZHU
Chinese Journal of Radiology 2019;53(11):1005-1011
Objective:
To synthesize a folic acid (FA)-modified pH-sensitive nanomicelle containing sorafenib (SF) and superparamagnetic iron oxide (SPIO), and to access its visibility in MRI and anti-cancer efficacy on hepatocellular carcinoma (HCC)
7.Transarterial chemoembolization combined with sorafenib and iodine-125 seed brachytherapy for hepatocellular carcinoma with portal vein tumor thrombus: a retrospective controlled study.
Jingjun HUANG ; Mingyue CAI ; Wensou HUANG ; Yongjian GUO ; Jingwen ZHOU ; Licong LIANG ; Liteng LIN ; Zhimei ZHOU ; Hui LIAN ; Mingji HE ; Kangshun ZHU
Chinese Medical Journal 2021;135(1):113-115